SDEV students share various professional career – planet status

He Columbia Climate School undergraduate office He recently organized his third annual panel of students’ racing conversations, with three students of the Sustainable Development Program (SDEV). The event offered an opportunity for current students from Columbia to learn about the various sectors and future professional career open to students interested in looking for climatic careers…

Read More

Start with a Bang #116 podcast – Disintegrant exoplanets | By Ethan Siegel | Start with an explosion! | APR, 2025

This image shows an illustration of an evaporating rock exoplanet, with a huge tail of dust that arises from the flying material from the planet from its interaction with the nearby star. (Credit: NASA/JPL-CALTECH) Exoplanets can exist anywhere around their matrices, even so close that they evaporate or disintegrate. Even the rocky. In the universe,…

Read More

MDPI publications resumption

MDPI publications resumption After a careful reflection and the light of the reflective comments of numerous authors, I have decided to resume publications of Publications of MDPI magazine. While previously I had chosen not to include content of this source, I now recognize that doing so would represent a lack of transparency and an involuntary…

Read More

Understanding lucid sleep could provide therapeutic benefits

Scientists have gradually changed their position on lucid dreams (LD), the ability to know that you are dreaming and even controlling your destiny within that dream state. Many were initially skeptical when, in the 1970s, Stanford’s psychophysiologist, Stephen Laberge, proposed the concept. Psychologists turned slowly, conducting research and taking advantage of the lucid dream capacity…

Read More

Cancer medicine unlocks the softer death for TB Culprit

A medication for cancer treatment currently in clinical trials could strengthen tuberculosis therapy by triggering a more controlled cell death process, which potentially reduces pulmonary damage in survivors, according to medicine researchers Johns Hopkins. The Navitoclax experimental medicine, when added to standard tuberculosis (TB) treatments, helped infected cells through a controlled process called apoptosis instead…

Read More